Ligand validation:4DTW

SRO: SEROTONIN

SRO is a Ligand Of Interest in 4DTW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4DTW_SRO_B_502	31%	22%	0.177	0.843	1.7	1.56	3	3	1	0	100%	1
4DTW_SRO_A_501	10%	21%	0.248	0.757	1.7	1.63	2	3	2	0	100%	1
4DUE_SRO_B_501	61%	11%	0.141	0.928	1.19	2.92	1	5	0	0	100%	1
4DUF_SRO_D_501	28%	5%	0.181	0.831	1.34	3.9	2	7	1	0	100%	1
2QEH_SRO_A_145	95%	16%	0.075	0.981	2.2	1.54	2	2	0	0	100%	1
8GDL_SRO_A_401	91%	41%	0.076	0.961	0.87	1.43	-	3	0	0	100%	1
2YMD_SRO_C_1213	90%	58%	0.082	0.965	0.88	0.75	-	-	1	0	100%	1
3BRN_SRO_A_158	89%	17%	0.103	0.982	2.09	1.56	2	2	0	0	100%	1
5MT9_SRO_W_101	88%	34%	0.087	0.964	1.39	1.23	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.